Intensification of Medication Therapy for Cardiorenal Syndrome in Acute Decompensated Heart Failure
Justin L. Grodin(The University of Texas Southwestern Medical Center), W.H. Wilson Tang(Cleveland Clinic), Adrian F. Hernandez(Duke University), G. Michael Felker(Clinical Research Institute), Javed Butler(Jackson Memorial Hospital), Edo Y. Birati(Bar-Ilan University), Bradley A. Bart(Hennepin County Medical Center), Divya Gupta(Emory University), Víctor G. Dávila‐Román(Washington University in St. Louis), Susanna R. Stevens(Mayo Clinic), Michael S. Kiernan(Tufts Medical Center), Kevin J. Anstrom(University of North Carolina at Chapel Hill), Lisa de las Fuentes(Washington University in St. Louis), Horng H. Chen, Kenneth B. Margulies(Temple University)
Cited by 62
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k
Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis
|Nature Medicine|2013|4.4k
2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2023|2.2k
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Journal of Heart Failure|2022|2.1k